Astrazeneca (AZN) Assets (2009 - 2026)
Astrazeneca (AZN) reported Assets of $115.83 billion for Q2 2026, up 3.0% from $112.42 billion a year earlier and up 1.6% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Astrazeneca posted Assets of $114.07 billion, up 9.6% from FY2024.
- Assets has increased for three consecutive years, with a five-year compound annual growth rate of 11.3% (FY2020 to FY2025).
- By year, Assets came in at $104.04 billion in FY2024 (+2.9%), $101.12 billion in FY2023 (+4.8%), $96.48 billion in FY2022 (-8.4%) and $105.36 billion in FY2021 (+57.9%).
- The Q2 2026 figure ranks as the highest quarterly Assets in data going back to Q1 2009.
- Year over year, Assets has now increased in each of the last 12 quarters, with growth averaging 6.6% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q3 2021 (growth of 67.2%); the low point was Q3 2022 (a decline of 12.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $114.02 billion (Q1 2026), $114.07 billion (Q4 2025) and $114.46 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 87.63 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 115.83 Bn |
| Mar 31, 2026 | 114.02 Bn |
| Dec 31, 2025 | 114.07 Bn |
| Sep 30, 2025 | 114.46 Bn |
| Jun 30, 2025 | 112.42 Bn |
| Mar 31, 2025 | 106.25 Bn |
| Dec 31, 2024 | 104.04 Bn |
| Sep 30, 2024 | 104.92 Bn |
| Jun 30, 2024 | 104.34 Bn |
| Mar 31, 2024 | 102.29 Bn |
| Dec 31, 2023 | 101.12 Bn |
| Sep 30, 2023 | 96.09 Bn |
| Jun 30, 2023 | 96.54 Bn |
| Mar 31, 2023 | 96.69 Bn |
| Dec 31, 2022 | 96.48 Bn |
| Sep 30, 2022 | 94.19 Bn |
| Jun 30, 2022 | 96.58 Bn |
| Mar 31, 2022 | 100.27 Bn |
| Dec 31, 2021 | 105.36 Bn |
| Sep 30, 2021 | 107.22 Bn |
API Access
Astrazeneca Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();